The Jacobson Lab focuses on how health care policies affect well-being. Much of Jacobson’s work focuses on the supply-side of health care markets, analyzing the effects of direct supply changes, for example hospital closures, on access to care and the impact of reimbursement policy on treatment and outcomes, specifically in the oncology market. Other work focuses on the demand side, assessing the risk-protective value of health insurance for consumers. In addition to being a professor at the Leonard Davis School, Jacobson is the co-director of the program on aging at USC’s Schaeffer Center for Health Economics and Policy and a research associate in the health care program at the National Bureau of Economic Research.

Focus Areas

Jacobson-Kleinman-circle

Professor of Gerontology
Assistant Dean of Academic Initiatives
Email: mireillj@usc.edu

Projects

  • Study testing both remote and in-person approaches to increase the diversity of participants in a brain health registry
  • Study testing approaches to increase COVID-19 booster vaccination rates
  • Analysis of differences in health care use for persons with dementia in traditional Medicare versus Medicare Advantage

Recent Publications

  1. Zissimopoulos, J, Thunell, J, Jacobson, M et al.. Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia.. Neurology. 2025;105 (3):e213717.
  2. Jacobson, M, Powell, D. Early estimates of awareness and uptake of over-the-counter naloxone.. Health Aff Sch. 2025;3 (6):qxaf107.
  3. Aisen, P, Peneva, D, Manetas, MA et al.. Advancing the science of recruitment for Alzheimer's clinical trials: Challenges and opportunities.. J Prev Alzheimers Dis. 2025; :100230.
  4. Jacobson, M, Powell, D. Price Sensitivity and Information Barriers to the Take-Up of Naloxone.. Am Econ J Econ Policy. 2024;16 (4):463-490.
  5. Powell, D, Jacobson, M. Estimates of Illicit Opioid Use in the US.. JAMA Health Forum. 2025;6 (5):e250809.
Search PubMed